Azole antifungal agents to treat the human pathogens Acanthamoeba castellanii and Acathamoeba polyphaga through inhibition of sterol 14a-demethylase (CYP51).

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)4707-4713
JournalAntimicrobiol. Agents Chemotherap.
StatePublished - May 15 2015

Fingerprint Dive into the research topics of 'Azole antifungal agents to treat the human pathogens Acanthamoeba castellanii and Acathamoeba polyphaga through inhibition of sterol 14a-demethylase (CYP51).'. Together they form a unique fingerprint.

  • Cite this